Tumors, Breast
Showing 1 - 25 of >10,000
Breast Tumors Trial
Not yet recruiting
- Breast Tumors
- (no location specified)
Aug 2, 2023
Breast Cancer Trial (CBD Oral, Control)
Not yet recruiting
- Breast Cancer
- CBD Oral
- Control
- (no location specified)
Nov 18, 2023
Breast Cancer Trial in Sittard (Pintuition)
Active, not recruiting
- Breast Cancer
- Pintuition
-
Sittard, Limburg, NetherlandsZuyderland Medical Center
Sep 19, 2023
HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and
Not yet recruiting
- HER2+ Advanced Breast Cancer
- Other Solid Tumors
- ADCC-R-Epo-R T-cells + Trastuzumab
- +2 more
- (no location specified)
Aug 31, 2023
Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)
Not yet recruiting
- Advanced Solid Tumor
- +8 more
- BGB-43395
- +2 more
- (no location specified)
Nov 13, 2023
Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)
Not yet recruiting
- Advanced Breast Cancer
- Advanced Lung Cancer
- Tumor-infiltrating lymphocytes
- IL-2
- (no location specified)
Oct 26, 2023
Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)
Not yet recruiting
- Breast Cancer
- +5 more
- PF-07224826
- Fulvestrant
- (no location specified)
Jun 7, 2023
Breast Cancer Trial in Nice (Metal wire, Radioactive Iodine Seed)
Active, not recruiting
- Breast Cancer
- Metal wire
- Radioactive Iodine Seed
-
Nice, FranceCentre Antoine LACASSAGNE
Jan 19, 2023
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)
Active, not recruiting
- Advanced Breast Cancer
- +2 more
- Talazoparib Tosylate
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 16, 2022
NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)
Not yet recruiting
- NSCLC
- +3 more
- YL202 should be intravenously infused
-
Chang chun, Jilin, ChinaJilin Provincial Cancer Hospital
Oct 25, 2023
Malignant Tumor of Breast, Benign Breast Lumps, High-Risk Breast Cancer Trial (MRI scan)
Not yet recruiting
- Malignant Tumor of Breast
- +2 more
- MRI scan
- (no location specified)
Mar 23, 2022
Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral
Not yet recruiting
- Advanced Breast Cancer
- +6 more
- Palbociclib Oral Product
- TAS-116
-
Providence, Rhode IslandLifespan Cancer Institute
Feb 1, 2023
Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)
Completed
- Metastatic Breast Cancer
- Solid Tumors
-
Aurora, ColoradoUniversity of Colorado Cancer Center
May 17, 2022
Breast Cancer, HER2-positive Breast Cancer Trial in Los Angeles (Omit breast radiation)
Not yet recruiting
- Breast Cancer
- HER2-positive Breast Cancer
- Omit breast radiation
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 10, 2022
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)
Not yet recruiting
- Adult Soft Tissue Sarcoma
- +4 more
- Ezabenlimab + BI907828
-
Bordeaux, France
- +5 more
Oct 19, 2023
Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)
Recruiting
- Triple Negative Breast Cancer
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Nov 13, 2023
Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)
Recruiting
- Breast Cancer
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Jul 20, 2022
Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))
Not yet recruiting
- Solid Tumors
- +4 more
- JAB-2485 (Aurora A inhibitor)
- (no location specified)
Aug 4, 2022
Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- +4 more
-
Houston, TexasMD Anderson
Mar 27, 2023
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Advanced Solid Tumor, Breast Cancer Trial in Columbus, San Antonio, West Valley City (CFI-402257, Fulvestrant)
Recruiting
- Advanced Solid Tumor
- Breast Cancer
-
Columbus, Ohio
- +2 more
Jul 26, 2022